Discover Great Companies Discover Great Clients
Popularity  6万   |   Followers  143   |   Likes  18   |   Feedback  92 Claim this company
No.346 Chengdu City Popularity Ranking No.117 High-tech District No.469 Sichuan Pr No.4 Zhi Shi Chan Quan Guan Biao No.4 Chemistry APIs No.8 Jian Kang Chan Industries No.8 Xin Xue Guan Yao No.10 Guo Chan Chemical No.10 Pharmaceutical APIs No.11 APIs No.17 Raw Materials No.31 Pharmaceutical No.33 Zhi Yao / Yao Industries No.44 Pharmaceutical Industrial Yi Zhi Agents 纳税大户 国家重点新产品 著名商标 省著名商标 市著名商标 高新技术企业 GMP认证
More

Company Overview

  • Nature: Private Enterprise Size: 100-499 employees Founded: 25年
  • Industry: Pharmaceutical/Biotechnology 、 Raw Materials and Processing 、 Beauty/Healthcare
  • Full name: Chengdu Hengrui Pharmaceutical Co., Ltd.。

Development Stage

  • Ranking: Ranked #346 in Chengdu City by popularity Ranked #4 in Chengdu Zhi Shi Chan Quan Guan Biao Company by popularity Ranked #4 in Chengdu Chemistry APIs Company by popularity Ranked #8 in Chengdu Jian Kang Chan Industries Company by popularity Ranked #8 in Chengdu Xin Xue Guan Yao Company by popularity
  • Honors: 纳税大户 国家重点新产品 According to algorithm
  • Salary: 74.8% of positions earn 8-15K, In 2026 vs last yeargrew by 24%.。.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 4%, "Computer/Network/Technology": 1.2%, "Mechanical/Instrumentation": 0.8%。
  • Recruiting: In 2026 vs 2025grew by 57%.
  • Requirement: Education: 大专 leads with 68.3%. Experience: 3-5年 leads with 44%.
  • Region: Distributed across 10 regions, 成都: 10%, 长沙: 5.8%, 福州: 4.2%, 南宁: 3.5%.

About the Company

I. Company Profile: Chengdu Hengrui Pharmaceutical Co., Ltd. is a pharmaceutical manufacturing enterprise jointly invested by Jiangsu Hengrui Pharmaceuticals Co., Ltd. and Sichuan Sheng'ao Pharmaceutical Co., Ltd., with its production base located in the Western Park of Chengdu High-tech Zone. Chengdu Hengrui first passed the GMP certification of the National Medical Products Administration in 2002 and started production in March 2003. In 2003, Chengdu Hengrui obtained the "High-tech Enterprise Certification" for the first time and has been awarded the title of Excellent High-tech Enterprise multiple times. From 2004 to 2014, Chengdu Hengrui was honored as a key taxpayer and one of the top 100 industrial taxpayers in Chengdu High-tech Zone for 11 consecutive years. Among large and medium-sized industrial enterprises in Sichuan, Chengdu Hengrui was awarded the certificate of "Top 30 Best-Efficiency Sichuan Pharmaceutical Manufacturing Industry" by the Sichuan Economic Commission and Sichuan Provincial Bureau of Statistics. Chengdu Hengrui owns two famous trademarks of Sichuan Province: Ainai (爱能) and Xianfudi (仙孚迪). Chengdu Hengrui has two famous brand products of Sichuan Province: Beishun (倍顺) and Xianfudi (仙孚迪). Chengdu Hengrui owns six well-known trademarks of Chengdu: Beterli (比特力), Beilexin (倍乐信), Aineng (爱能), Xianfudi (仙孚迪), Beishun (倍顺), and Shuangneng (爽能). II. Sales Model: The company's sales model is direct sales through pharmacies, using pharmacies as a platform to drive drug sales by providing professional services to patients with hypertension, hyperglycemia, and hyperlipidemia (the "three highs"). With the advent of the Internet+ era, the company has established a distinctive WeChat public account providing a patient self-check platform, combined with direct pharmacy sales, creating a novel O2O marketing model. The so-called "O2O" refers to integrating offline business opportunities with the Internet, making the Internet a front-end for offline transactions. Numerous successful marketing cases have been generated through this approach. III. "Three Highs" Product Series: Chengdu Hengrui Pharmaceutical Co., Ltd. is a professional enterprise in the production and sales of domestic drug series for diabetes, hypertension, and hyperlipidemia. The company offers the first localized metformin hydrochloride extended-release tablets and gliclazide extended-release tablets, the first rosiglitazone tablets (an insulin sensitizer) manufactured and marketed domestically, metformin hydrochloride and glibenclamide tablets (a compound antidiabetic drug for intensified blood glucose control), simvastatin tablets for comprehensively reversing dyslipidemia, losartan potassium capsules (an antihypertensive drug protecting vital organs), and Difrarel tablets (a French imported drug for treating diabetic retinopathy), among other series of drugs for treating the "three highs." The company also has a large number of drugs under development for treating the "three highs," such as new antidiabetic drugs (e.g., DPP-4 inhibitors and SGLT-2 inhibitors), new lipid-lowering drugs (e.g., ezetimibe), and new antihypertensive drugs.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Hengrui Pharmaceutical How Fast Is Hiring Growing? (137 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 324%
  • 2024: Up 62%
  • 2023: Up 950%
  • 2022: Down 98%
Hengrui Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at Chengdu Hengrui Pharmaceutical Co., Ltd. growing? Hengrui Pharmaceutical2026: 226 openings (up 57%), 2025: 144 openings (up 324%), 2024: 34 openings (up 62%), 2023: 21 openings (up 950%), 2022: 2 openings (down 98%), 2021: 86 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Hengrui Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Chengdu Hengrui Pharmaceutical Co., Ltd.? Based on an analysis of Hengrui Pharmaceutical's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 4%, "Computer/Network/Technology": 1.2%, "Mechanical/Instrumentation": 0.8%, "Other (R&D and Technical)": 0.4%. For reference only.

Hengrui Pharmaceutical — What Are the Salaries Like? (250 records)

Manage
Hengrui Pharmaceutical Salary Overview
salary range: 3K - 20K, 74.8% of roles pay ¥8-15K
Note: salary statistics are based on 250 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Chengdu Hengrui Pharmaceutical Co., Ltd.?Hengrui Pharmaceutical74.8% of positions earn 8-15K, Undergraduate salary: ¥。Chengdu salary ranking: #3363,Sales average salary ¥9.5K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Hengrui Pharmaceutical

(More)
Are salaries high at Chengdu Hengrui Pharmaceutical Co., Ltd.? We provide: Area Manager, Sales, Provincial Manager, Account Manager, Supervisor, Regional Manager, Team Manager, QC, 内勤, Marketing, Promotion Specialist, 申报专员, 西医, 健康顾问, Analyst, Driver, Regional Manager, Application Technician, Operator, General Worker. Click to view detailed salary analysis by job.

Job Category

  • Sales
    95.8% of total 95.8%
  • Business Management
    34.7% of total 34.7%
  • Medical & Health/Beauty & Healthcare
    3.9% of total 3.9%
  • Quality Management
    3.1% of total 3.1%

Education

  • 大专
    68.3% of total 68.3%
  • 不限
    25.1% of total 25.1%
  • 高中
    3.5% of total 3.5%
  • 本科
    2.3% of total 2.3%

Experience

  • 3-5年
    44% of total 44%
  • 5-10年
    38.2% of total 38.2%
  • 不限
    15.1% of total 15.1%
  • 1-3年
    2.7% of total 2.7%
View Detailed Analysis

What does Chengdu Hengrui Pharmaceutical Co., Ltd. require? Who is Hengrui Pharmaceutical hiring? Hengrui Pharmaceutical recruitment: Sales占比最多占95.8%,其次是Business Management占34.7%. What education can get in at Hengrui Pharmaceutical? 大专占比最多占68.3%,其次是不限占25.1%. Work experience required at Hengrui Pharmaceutical? 3-5年占比最多占44%,其次是5-10年占38.2%. Where are the job locations at Hengrui Pharmaceutical? 成都占比最多占10%,其次是长沙占5.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 2,918万(元)
Legal Representative: 沈柏清
Date Established:
Credit Code: 91510100727431952L
Registered Address: 成都高新区西部园区百草路18号

Partners & Suppliers

向成都恒瑞制药供应原料药 Source
供应商 原料药
向成都恒瑞制药供应抗生素等原料药 Source
供应商 原料药
成都恒瑞制药通过国药控股分销药品 Source
合作客户 医药商业
向成都恒瑞制药供应药用辅料 Source
供应商 药用辅料
采购盐酸二甲双胍原料药 Source
供应商 化学制剂生产商

People who follow Hengrui Pharmaceutical also follow

Hengrui Pharmaceutical Competitors (Similar Companies)

保险 寿险 健康保险 财产保险
“Provides nutritious, healthy, and delicious dairy products to consumer”
抗震支架 吊架 支吊架 建材
“Main business covers four major sectors: medical protection, rehabilit”
“Anheng Empowers Secure China”
智能建筑 工程承包 机电设备安装 工程总承包/EPC
“Products for the diagnosis and treatment of allergic diseases”
“IC packaging and testing”
“Comprehensive solutions for information communication and power energy”
新材料 甲醇 异丁烯 化工新材料
“我们一起创造We make it together”
“Full-scenario immunodiagnostic technology platform”
机械制造/生产/加工 工程机械 注塑机 马达
“Originator and advocate of the "specialty-specific" monitor concept in”
“Focused on providing personalized genetic testing solutions and produc”

Discover Great Companies, Discover Great Clients

成都公司名录 成都“High-tech Zone”公司名录 成都“制药/药业”公司名录 成都“原料药”公司名录 成都“心血管药”公司名录 成都“原料”公司名录 成都“化学原料药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates